Results 141 to 150 of about 46,120 (196)

Extended Release Micro-Pellets of Chiral Molecule of Metoprolol Succinate by Fluid Bed Technology

open access: yesInternational Journal of Pharmaceutical Sciences and Drug Research, 2017
The objective is to prepare extended release micro-pellets of the s-Metoprolol Succinate which is chirally pure molecules. Commercially Metoprolol Succinate is available the racemic mixture of the s and r isomers.
Bhupendra G Prajapati
exaly   +2 more sources

Effect of naringenin on the pharmacokinetics of metoprolol succinate in rats

Xenobiotica, 2021
The aim of the present study was to investigate the effect of naringenin (4,5,7-trihydroxy flavonone) on the pharmacokinetics of metoprolol, a substrate of Cytochrome P-450 3A4 (CYP3A4), CYP2C9, and CYP2D6 in rats.Male Wistar rats were treated orally with metoprolol (30 mg/kg) alone and in combination with naringenin (25, 50, and 100 mg/kg) once daily ...
Ravindra Babu, Pingili   +5 more
openaire   +2 more sources

A new polymorphic form of metoprolol succinate

Pharmaceutical Development and Technology, 2016
Only one crystal form of metoprolol succinate (Form I) was reported during previous researches and production. In this study, a new polymorph of metoprolol succinate (here named as Form II) was discovered and investigated by X-ray diffraction, thermoanalysis and infrared spectroscopy.
Mengqing, Zhou   +6 more
openaire   +2 more sources

Metoprolol Succinate Combination in the Treatment of Hypertension

Angiology, 2008
Metoprolol is a selective β(l)-adrenergic antagonist extensively used since 1975. Metoprolol has proven its efficacy in reducing cardiovascular events and mortality in patients with hypertension and coronary heart disease. A recently developed controlled release/extended-release formulation of metoprolol succinate was designed to provide relatively ...
Dimitris P, Papadopoulos   +1 more
openaire   +2 more sources

Marked hypertriglyceridemia in a woman receiving metoprolol succinate

Journal of Clinical Lipidology, 2014
β-blockers are commonly used therapies after acute myocardial infarction and in the management of congestive heart failure and hypertension. We report a case of a middle-aged woman with a history of mild hypertension who was placed on metoprolol succinate.
Yeunjung, Kim, Michael, Miller
openaire   +2 more sources

Controlled release of Metoprolol Succinate from the organo-mineral complex Metoprolol Succinate-Montmorillonite

2022
Due to the current need to prolong the action of a drug and reduce the side effects that can be generated in the patient, a large number of scientific investigations have been developed that focus on the implementation of systems that cover the needs set out above, giving origin thus to controlled release systems.
Pérez Niño, Laura Marcela   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy